AI startups targeting the healthcare sector have shown great promise in recent years, but they must navigate unique challenges to succeed. While the potential for innovation in clinical care, administrative efficiencies, and patient outcomes is immense, these startups must overcome several key
The European Union's pioneering AI Act, poised to dramatically alter the landscape of healthcare and life sciences across Europe, shines a spotlight on the urgent need for compliance among companies involved in AI applications from production to clinical operations. As the regulation drives
Gene therapy has ushered in a new era of medical possibilities, offering groundbreaking treatments for debilitating and often fatal diseases. One of the most prominent examples is Lenmeldy (atidarsagene autotemcel), a gene therapy developed by Orchard Therapeutics and recently acquired by Kyowa
Pharmaceutical safety is a multifaceted and crucial aspect of public health, involving systematic efforts, regulations, and the collective responsibility of individuals. Ensuring the efficacy and safety of drugs requires vigilance from regulatory bodies, healthcare professionals, the pharmaceutical
Cell and gene therapy hold tremendous promise for treating a wide array of diseases, including many that were previously considered untreatable. However, the high production costs associated with these advanced treatments pose a significant barrier to their widespread adoption. Automation emerges
The fields of cell and gene therapy have seen remarkable advancements and transformative updates over the past few years. As biotechnology companies strive to innovate and deliver groundbreaking solutions, significant milestones have been achieved, fostering hope and optimism for addressing some of
